Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 2
1948 1
1953 1
1962 2
1963 2
1964 4
1965 3
1966 3
1967 3
1968 10
1969 6
1970 10
1971 13
1972 16
1973 12
1974 4
1975 8
1976 4
1977 5
1978 3
1979 13
1980 7
1981 10
1982 9
1983 18
1984 11
1985 6
1986 17
1987 10
1988 12
1989 10
1990 17
1991 10
1992 8
1993 12
1994 14
1995 8
1996 5
1997 3
1998 2
1999 6
2000 3
2001 4
2002 4
2003 14
2004 2
2005 9
2006 7
2007 6
2008 9
2009 8
2010 8
2011 3
2012 7
2013 11
2014 9
2015 6
2016 2
2017 8
2018 18
2019 32
2020 29
2021 22
2022 14
2023 14

Text availability

Article attribute

Article type

Publication date

Search Results

536 results

Results by year

Filters applied: . Clear all
Page 1
Current state of melanoma diagnosis and treatment.
Davis LE, Shalin SC, Tackett AJ. Davis LE, et al. Cancer Biol Ther. 2019;20(11):1366-1379. doi: 10.1080/15384047.2019.1640032. Epub 2019 Aug 1. Cancer Biol Ther. 2019. PMID: 31366280 Free PMC article. Review.
Acute Bacterial Meningitis.
Davis LE. Davis LE. Continuum (Minneap Minn). 2018 Oct;24(5, Neuroinfectious Disease):1264-1283. doi: 10.1212/CON.0000000000000660. Continuum (Minneap Minn). 2018. PMID: 30273239 Review.
Recent advances in therapies for eating disorders.
Davis LE, Attia E. Davis LE, et al. F1000Res. 2019 Sep 26;8:F1000 Faculty Rev-1693. doi: 10.12688/f1000research.19847.1. eCollection 2019. F1000Res. 2019. PMID: 31598212 Free PMC article. Review.
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Gounder M, et al. Among authors: davis le. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. N Engl J Med. 2023. PMID: 36884323 Clinical Trial.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S. Tawbi HA, et al. Among authors: davis le. Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4. Lancet Oncol. 2017. PMID: 28988646 Free PMC article. Clinical Trial.
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group. Oxman MN, et al. Among authors: davis le. N Engl J Med. 2005 Jun 2;352(22):2271-84. doi: 10.1056/NEJMoa051016. N Engl J Med. 2005. PMID: 15930418 Free article. Clinical Trial.
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
Davis LE, Bolejack V, Ryan CW, Ganjoo KN, Loggers ET, Chawla S, Agulnik M, Livingston MB, Reed D, Keedy V, Rushing D, Okuno S, Reinke DK, Riedel RF, Attia S, Mascarenhas L, Maki RG. Davis LE, et al. J Clin Oncol. 2019 Jun 1;37(16):1424-1431. doi: 10.1200/JCO.18.02374. Epub 2019 Apr 23. J Clin Oncol. 2019. PMID: 31013172 Free PMC article. Clinical Trial.
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Gounder M, Schöffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, Attia S, Chugh R, Chen TW, Jahan T, Loggers ET, Gupta A, Italiano A, Demetri GD, Ratan R, Davis LE, Mir O, Dileo P, Van Tine BA, Pressey JG, Lingaraj T, Rajarethinam A, Sierra L, Agarwal S, Stacchiotti S. Gounder M, et al. Among authors: davis le. Lancet Oncol. 2020 Nov;21(11):1423-1432. doi: 10.1016/S1470-2045(20)30451-4. Epub 2020 Oct 6. Lancet Oncol. 2020. PMID: 33035459 Clinical Trial.
Histone Modifications as Biomarkers for Immunotherapy.
Taylor EM, Koss B, Davis LE, Tackett AJ. Taylor EM, et al. Among authors: davis le. Methods Mol Biol. 2020;2055:213-228. doi: 10.1007/978-1-4939-9773-2_10. Methods Mol Biol. 2020. PMID: 31502154 Review.
536 results